We are live on ! Find out more
MBIO icon

Mustang Bio

36 hedge funds and large institutions have $17.9M invested in Mustang Bio in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

392% more capital inflows, than outflows

Capital inflows: $13.7M | Capital outflows: $2.78M

350% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 2

300% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 5

71% more funds holding

Funds holding: 21 → 36 (+15)

5.06% more ownership

Funds ownership: 4.9% → 9.97% (+5.1%)

Holders
36
Holders Change
+15
Holders Change %
+71.43%
% of All Funds
0.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
9
Reduced
2
Closed
5
Calls
$249K
Puts
–
Net Calls
+$249K
Net Calls Change
+$249K

MBIO Hedge Fund Activity: Q2 2018 in Review

36 of the 4,386 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q2 2018, worth a combined $17.9M — up 32% from $13.5M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new MBIO positions and 5 closed out — a net gain of 15 holders — while 9 added to existing stakes and 2 trimmed.

The largest buyer was BlackRock, adding an estimated $6.43M. The largest seller was Millennium Management, exiting entirely with an estimated $1.1M sold.

  • 36 institutional investors held Mustang Bio (MBIO) as of Q2 2018, up from 21 in Q1 2018.
  • Funds reported $17.9M of Mustang Bio stock for Q2 2018, up 32% quarter-over-quarter.
  • 20 funds opened new Mustang Bio positions in Q2 2018 and 5 closed out, a net change of +15 holders.
  • The largest Mustang Bio buyer in Q2 2018 was BlackRock, an estimated $6.43M added.
  • The largest Mustang Bio seller in Q2 2018 was Millennium Management, an estimated $1.1M sold.

Based on aggregated 13F filings for Q2 2018.